Format

Send to

Choose Destination
J Surg Oncol. 1981;16(3):273-7.

Intracavitary bleomycin for the control of malignant effusions.

Abstract

The results of treatment with intracavitary bleomycin are reported in twenty patients with a malignant pleural effusion and five patients with malignant ascites. The control rate was 17/20 (85%) patients with malignant pleural effusions and 3/5 (60%) patients with malignant ascites. Toxicities were minimal with fever being the most common side effect in four patients (16%. Bleomycin is an effective and nontoxic sclerosing agent.

PMID:
6163930
DOI:
10.1002/jso.2930160312
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center